CANF

CANF Other Income/Expenses (Net)

$179.00KTTM · USD

Period ending:

CANF FY Other Income/Expenses (Net)USD
CANF FY Other Income/Expenses (Net)2010-12-31: $152.48K2011-12-31: -$2.63M2012-12-31: $137.58K2013-12-31: $146.16K2014-12-31: $840.28K2015-12-31: $1.35M2016-12-31: $269.86K2017-12-31: $781.00K2018-12-31: -$1.15M2019-12-31: -$618.00K2020-12-31: -$304.00K2021-12-31: $227.00K2022-12-31: -$77.00K2023-12-31: $561.00K2024-12-31: $250.00K2025-12-31: $122.97K$1.35M-$2.63M
2010-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CANF other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 16 observations from Dec 31, 2010 to Dec 31, 2025.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
122,968
250,000
561,000
-77,000
227,000
-304,000
-618,000
-1,153,000
781,000
269,858
1,354,882
840,282
146,159
137,582
-2,627,430
152,480

Compare other income/expenses (net)

All CANF financial metrics · CANF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.